Medexus Pharmaceuticals Inc (OTCPK:MEDXF)
$ 1.509 0.124 (8.95%) Market Cap: 37.62 Mil Enterprise Value: 72.91 Mil PE Ratio: 30.18 PB Ratio: 1.17 GF Score: 69/100

Q4 2024 Medexus Pharmaceuticals Inc Earnings Call Transcript

Jun 26, 2024 / 12:00PM GMT
Release Date Price: $1.26
Operator

Good morning, everyone, and welcome to the Medexus Pharmaceuticals fourth fiscal quarter and 2024 fiscal year conference call. (Operator Instructions) Please note this conference is being recorded.

I will now turn the conference over to your host, Victoria Rutherford, Investor Relations, at Medexus. Over to you.

Victoria Rutherford
Medexus Pharmaceuticals Inc - IR Contact Officer

Thank you, and good morning, everyone, welcome to the Medexus Pharmaceuticals fourth quarter and fiscal 2024 earnings call. On the call this morning are Ken dâEntremont, Chief Executive Officer; and Marcel Konrad, Chief Financial Officer. If you have any additional questions after the conference call forward like further information about the company, please contact (technical difficulty) 480-625-5772 .

I would like to remind everyone that this discussion will include forward-looking information as defined in securities laws. Actual results may differ materially from historical results or results anticipated by the forward-looking information. In addition, this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot